O. Teglia

发表

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.

C. Tanaseanu, N. Dartois, G. Dukart, 2008, Diagnostic microbiology and infectious disease.

Leptospiral pneumonia.

B. Cunha, O. Teglia, C. Battagliotti, 1995, Chest.

Malassezia furfur Infections

B. Cunha, P. Schoch, O. Teglia, 1991, Infection Control & Hospital Epidemiology.

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

Arthur J. L. Cooper, G. Dukart, R. Mallick, 2009, Diagnostic microbiology and infectious disease.

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

J. Milanowski, T. File, D. Górecka, 2011, The Journal of antimicrobial chemotherapy.

P846 ATLAS 2: a double-blind, randomised, active controlled, multinational Phase 3 study comparing telavancin with vancomycin for the treatment of patients with complicated skin and skin structure infections

V. Fowler, G. Corey, S. Barriere, 2007 .